- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
What Makes People with Myeloproliferative Neoplasms Unique?
Carole Brennan Miller, M.D., head of the Cancer Institute at Saint Agnes Hospital, explains what makes people with myeloproliferative neoplasms (MPNs) unique, and why she finds it interesting to work with them.
Carole Brennan Miller, M.D., head of the Cancer Institute at Saint Agnes Hospital, works with many people who have myeloproliferative neoplasms (MPNs). When asked what she likes about working with this group, she explained that because their cancer is more of a chronic disease that they live with for a long time, they often have multiple touchpoints with the medical community, know a lot about their disease, advocate for themselves, and tend to be interested in exploring different treatment options.
FDA Approves Ojjaara to Treat Myelofibrosis With Anemia
September 15th 2023The FDA approved Ojjaara for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anemia.
Read More
